Pacific Biosciences: Q2 Earnings Snapshot

August 3, 2022 GMT

MENLO PARK, Calif. (AP) _ Pacific Biosciences of California Inc. (PACB) on Wednesday reported a loss of $71.4 million in its second quarter.

On a per-share basis, the Menlo Park, California-based company said it had a loss of 32 cents. Losses, adjusted for non-recurring gains, were 34 cents per share.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 34 cents per share.

The maker of genetic analysis technology posted revenue of $35.5 million in the period, which also met Street forecasts.

Pacific Biosciences expects full-year revenue in the range of $138 million to $145 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PACB at